iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, placebo-controlled, double-blind clinical trial. The
primary focus of the study is the evaluation of the effectiveness of treatment with megestrol
as part of a 24 week behavioral feeding protocol in transitioning from tube to oral feedings
in a pediatric population. Approximately 60 pediatric subjects matching the criteria for
eligibility will be enrolled in the study and randomized to receive either megestrol (n=30)
or placebo (n=30).